Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Appl Physiol Nutr Metab ; 43(4): 355-362, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29091740

RESUMO

We hypothesized that along with exercise, casein peptide supplementation would have a higher impact on improving glucose tolerance than intact casein. Male 6-week-old ICR mice were provided a high-fat diet to induce obesity and glucose intolerance. The mice were randomly divided into 4 treatment groups: control (Con), endurance training (Tr), endurance training with intact casein supplementation (Cas+Tr), and endurance training with casein peptide supplementation (CP+Tr). The mice in each group were orally administrated water, intact casein, or casein peptide (1.0 mg/g body weight, every day), and then subjected to endurance training (15-25 m/min, 60 min, 5 times/week for 4 weeks) on a motor-driven treadmill 30 min after ingestion. Our results revealed that total intra-abdominal fat was significantly lower in CP+Tr than in Con (p < 0.05). Following an oral glucose tolerance test, the blood glucose area under the curve (AUC) was found to be significantly smaller for CP+Tr than for Con (p < 0.05). Moreover, in the soleus muscle, glucose transporter 4 (GLUT4) protein levels were significantly higher in CP+Tr than in Con (p < 0.01). However, intra-abdominal fat, blood glucose AUC, and GLUT4 protein content in the soleus muscle did not alter in Tr and Cas+Tr when compared with Con. These observations suggest that pre-exercise casein peptide supplementation has a higher effect on improving glucose tolerance than intact casein does in mice fed a high-fat diet.


Assuntos
Glicemia/metabolismo , Caseínas/administração & dosagem , Dieta Hiperlipídica , Suplementos Nutricionais , Intolerância à Glucose/dietoterapia , Fragmentos de Peptídeos/administração & dosagem , Adiposidade , Animais , Biomarcadores/sangue , Modelos Animais de Doenças , Ingestão de Energia , Intolerância à Glucose/sangue , Intolerância à Glucose/etiologia , Intolerância à Glucose/fisiopatologia , Transportador de Glucose Tipo 4/metabolismo , Gordura Intra-Abdominal/metabolismo , Gordura Intra-Abdominal/fisiopatologia , Masculino , Camundongos Endogâmicos ICR , Músculo Esquelético/metabolismo , Obesidade/sangue , Obesidade/fisiopatologia , Fatores de Tempo , Aumento de Peso
2.
J Oleo Sci ; 66(8): 917-924, 2017 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-28701655

RESUMO

Previous studies have shown that medium-chain triacylglycerols (MCTs) exert favorable effects on protein metabolism. This study evaluated the effects of the dietary intake of MCTs on rat skeletal muscle mass and total protein content during casting-induced hindlimb immobilization, which causes substantial protein degradation and muscle atrophy. Rats were fed a standard diet containing long-chain triacylglycerols (LCTs) or MCTs for 3 days and then a unilateral hindlimb was immobilized while they received the same diet. After immobilization for 3, 7, and 14 days, muscle mass and total protein content in immobilized soleus muscle in the LCT-fed rats had markedly decreased compared to the contralateral muscle; however, these losses were partially suppressed in MCT-fed rats. Autophagosomal membrane proteins (LC-I and -II), which are biomarkers of autophagy-lysosome activity, did not differ significantly between the LCT- and MCT-fed rats. In contrast, the immobilization-induced increase in muscle-specific E3 ubiquitin ligase MuRF-1 protein expression in immobilized soleus muscle relative to contralateral muscle was completely blocked in the MCT-fed rats and was significantly lower than that observed in the LCT-fed rats. Collectively, these results indicate that the dietary intake of MCTs at least partly alleviates immobilization-induced muscle atrophy by inhibiting the ubiquitin-proteasome pathway.


Assuntos
Suplementos Nutricionais , Elevação dos Membros Posteriores/efeitos adversos , Atrofia Muscular/etiologia , Atrofia Muscular/prevenção & controle , Triglicerídeos/administração & dosagem , Animais , Autofagia , Moldes Cirúrgicos , Elevação dos Membros Posteriores/métodos , Lisossomos , Masculino , Proteínas Musculares/metabolismo , Músculo Esquelético/metabolismo , Complexo de Endopeptidases do Proteassoma/metabolismo , Proteólise/efeitos dos fármacos , Ratos Wistar , Transdução de Sinais/efeitos dos fármacos , Fatores de Tempo , Triglicerídeos/química , Triglicerídeos/farmacologia , Proteínas com Motivo Tripartido/metabolismo , Ubiquitina/metabolismo , Ubiquitina-Proteína Ligases/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA